Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care

By afschroeder • July 10, 2025

El Rafei A, Gosch K, Manning ES, Ghajar A, Raghavan S, Maddox TM, Peterson PN, Fleming L, Arnold SV, Chan PS, Greene SJ, Fonarow GC, Jones PG, Allen LA, Hess PL. Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care. JAMA Cardiol. 2025 Jul 9. doi: 10.1001/jamacardio.2025.2145. Epub ahead of print. PMID: 40632519.

Tags: Cardiology/Epi, Publications

Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with 177Lu-PSMA: A Retrospective, Single-Center Study

Murthy V, Kimura K, Theus L, Nguyen A, Lokre O, Perk T, Thin P, Nguyen K, Ludwig V, Chen L, Gafita A, Czernin J, Calais[...]

Associations of Plasma Trimethylamine N-Oxide-Related Metabolites with the Development and Progression of Albuminuria: The Multi-Ethnic Study of Atherosclerosis

Wang M, Tang WHW, Li XS, de Oliveira Otto MC, Lemaitre RN, Fretts A, Nemet I, Sotoodehnia N, Sitlani CM, Budoff M, DiDonato JA, Wang[...]

Methadone Blockade of Inward Rectifier Potassium Current Promotes Both Early and Delayed Repolarization Arrhythmias: Mechanistic Insights From Computational Modeling

Zhang Z, Green JT, Haigney MC, Walker P, Shivkumar K, Garfinkel A, Qu Z. Methadone Blockade of Inward Rectifier Potassium Current Promotes Both Early and[...]